About Valocor Therapeutics

About company

Valocor Therapeutics, Inc., a clinical stage biotech company, develops new therapies to treat dermatological conditions with unmet medical needs. Its products include Lemuteporfin, a potent and selective topical photodynamic therapy approach to sebaceous gland targeting for severe acne; VAL-001, a topical sebum inhibitor targeting acne and sebaceous gland hyperactivity; VAL-002, a small-molecule kinase-inhibitor for topical treatment of chronic inflammatory skin diseases; and VAL-003, a Kinase inhibitor with dual melanin-stimulating and immune-modulating activities. Valocor Therapeutics, Inc. was founded in 2008 and is based in Vancouver, Canada.